Skip to content
GinjerNews

The GuardianLifestyle

FDA warns of rare eye condition causing blindness from GLP-1 weight loss medications

By Maya Yang

The federal agency is requiring all GLP-1s to include information about the potential risk on warning labels The US Food and Drug Administration (FDA) has issued a new warning on GLP-1 medications – which can facilitate weight loss – over a rare eye condition that could lead to sudden and permanent blindness. On Monday, the FDA announced that it is requiring all GLP-1 medications – including Novo…

This story was published by The Guardian. Read the full article on their site.

Read the full story at theguardian.com(opens in a new tab)

More Lifestyle